Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Pharmacogenomics of Antidepressant Response in Children and Adolescents.

Next Previous
Trial Profile

Pharmacogenomics of Antidepressant Response in Children and Adolescents.

Status: Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 18 Sep 2021

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Adrenergic uptake inhibitors; Serotonin uptake inhibitors
  • Indications Anxiety disorders; Depressive disorders; Eating disorders; Obsessive-compulsive disorders
  • Focus Adverse reactions; Pharmacogenomic
  • Acronyms PARCA

Most Recent Events

  • 17 Apr 2015 Biomarkers information updated
  • 23 Jan 2013 Planned end date changed from 1 Dec 2012 to 1 Sep 2013 as reported by ClinicalTrials.gov.
  • 18 Apr 2012 Planned end date changed from 1 Jul 2009 to 1 Dec 2012 as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top